New high fidelity market information can help. CareSet Systems unlocks Medicare data to decode patient journeys and provide real-world evidence for targeting, getting the right drugs to the right patients, faster. Marketing directors invest billions to launch new drugs based on limited samples and summaries that don’t track patients across care settings or geographies. Without comprehensive analysis, predicting market demand is challenging and risky.
CareSet’s Featured Products
For those with more defined market analysis needs, CareSet Target facilitates insight into targeted physician populations. You define the boundaries and Target provides insight into the health care and delivery trends within that market. Insights include physician autonomy and specialization, referral trends, therapy volumes and practice growth.
CareSet Target data has been used by Marketing, Brand Management and Sales leaders to deliver specific insights into physician and referrals. For indications that target age-related populations, Medicare data insights are especially valuable for salesforce alignment, projecting therapy volumes and measuring competitor uptake.
Deliverables include both custom data file(s) and summary report(s). CareSet works in partnership to design and scope Physician Segmentation and Targeting, manage shared responsibilities throughout and deliver actionable insights as a result. Depending on preference for raw data and consulting analysis outputs, CareSet will assign the right level of consulting expertise to ensure benefits of data insights are realized.Request a Demo
CareSet Affiliation empowers your market research with insight into hospital and medical group opinion leaders and their internal and external referral behaviors. Affiliation allows you to cut through the confusion and identify the interactions that matter most to your marketing efforts.
- Feeding quarterly market updates for field intelligence
- Quantitative measurement of network, clinic, and outcomes management
- Network adequacy and robust
Differentiating the KOLs within hospitals and medical groups requires insight into its physician roster, and distribution of referral from within and outside. For certain specialties, providers are often working from many, sometimes competing hospitals, as well as contracted to several medical groups and services.
CareSet cuts through all of these connections objectively by following the streams of each provider’s reimbursements, across all their sites, settings, and organizations saving sales and marketing thousands of hours of research. CareSet also maintains these affiliations, updating them quarterly, for every provider working with Medicare to serve patients.Request a Demo
CareSet Journey is about how patient populations, selected from a pool of 54 million Medicare patients, move through and utilize the various services of the healthcare enterprise. Journey allows you to identify cohorts of Medicare data and quantify how geography, physician and provider selection affect patient health care decisions and outcomes. Among the insights Journey provides are competitive trends at the health care provider level, referral and competitive trends, and longitudinal data studies for Part A, B and D Medicare claims data.
Track cohorts of Medicare patients through the healthcare system in the years before and after a diagnosis. Quantify how geography, physician type and provider selection impact the treatments received, pathways and health outcomes.
- Identify groups of patients to target at, or even before, diagnosis
- Visualize the patient journey across sites of care
- Compare patient outcomes for therapeutic interventions over time
CareSet Market View
With reports developed for a number of patient populations, CareSet Market View provides you with Part A, B, C and D claims information for over 50 million Medicare patients, distributed nationally. Available reports include, among others, oncology, hematology, HIV and Alzheimer’s disease. Our reports are intended for those whose business, clinical or data science initiatives stand to benefit from a clear, jargon-free, fact-filled analysis of market dynamics and utilization.
Executives, Research and Development and Health Economics and Outcomes Research groups are accessing CareSet data. Marketing leaders and large Group Purchasing Organizations are now expressing interest. Reports have been used to simply validate existing sample or non-Medicare data as the basis for major strategic change in addressing Medicare populations. Established leaders and smaller pharma companies developing new therapies are leveraging CareSet Market View for market sizing, population profiling, and reimbursement comparisons. Many clients already have access to detailed internal or purchased data or samples from Medicare. CareSet Market View can provide a comparison and additional source to create the most comprehensive data set.
CareSet Market View reports are readable and accessible with limited jargon and a glossary, ideal for a range of business, clinical and data science audiences. Analyses provided at a high level can spur further discussion and strategic insights all based on the facts. For research teams, highlighting potential areas of differentiation among Medicare populations is a key feature.
CareSet accesses over 50 million Medicare patients with claims link between Part A, B, C and D at the provider (NPI) level. Reports are prepared by indication or are available as a suite for electronic distribution. Underlying data use to create reporting is based on CareSet Cube and a comprehensive referral and provider map.
Reports are available for multiple indications:
- Alzheimer’s disease and Dementia
- Hepatitis C
- Psoriasis and related dermatological indications
- Cardiac disease
- Rare orphan disease